A study published in the journal BMC Complementary and Alternative Medicine revealed that the Indian gooseberry (Emblica officinalis) can potentially lower cholesterol and triglyceride levels. In the study, researchers from India examined the efficacy of the Indian gooseberry in individuals with dyslipidemia.
Dyslipidemia is one of the most common risk factors for the development of atherosclerosis and other heart disorders. It is characterized by high levels of triglycerides and total cholesterol in the blood.
In conducting the study, the researchers recruited 98 participants and divided them into two groups: a treatment and a placebo group. Participants in the treatment group received 500 milligrams (mg) of the Indian gooseberry extract, while the other group received a placebo capsule.
The extract and placebo were given twice every day for 12 weeks.
After the treatment period, the researchers measured the lipid profiles of the participants.
They also looked at the effect of the Indian gooseberry extract on other markers of cardiovascular disease, as well as fasting blood glucose and Coenzyme Q10 (CoQ10), which acts as an antioxidant.
Results showed that the Indian gooseberry treatment significantly improved the lipid profiles of the participants.
It reduced levels of total cholesterol, triglycerides, low-density lipoprotein (LDL) cholesterol, and very low-density lipoprotein (VLDL) cholesterol.
In addition, the markers of cardiovascular disease were reduced by the Indian gooseberry extract.
The researchers also observed a general trend of fasting blood glucose reduction, suggesting a potential hypoglycemic effect.
Indian gooseberry also did not affect CoQ10 levels, unlike statin drugs.
In conclusion, Indian gooseberry can be used as a safe and effective way to treat dyslipidemia and improve cardiovascular health.
To read more studies on the health benefits of the Indian gooseberry, visit NaturalCures.news.
Upadya H, Prabhu S, Prasad A, Subramanian D, Gupta S, Goel A. A RANDOMIZED, DOUBLE BLIND, PLACEBO CONTROLLED, MULTICENTER CLINICAL TRIAL TO ASSESS THE EFFICACY AND SAFETY OF EMBLICA OFFICINALIS EXTRACT IN PATIENTS WITH DYSLIPIDEMIA. BMC Complementary and Alternative Medicine. 22 January 2019; 19:27. DOI: 10.1186/s12906-019-2430-y